Cleared Traditional

K821657 - RIAGEN B-HCG RIA

K821657 is an FDA 510(k) clearance for RIAGEN B-HCG RIA, manufactured by Biogenex Laboratories. The device is a Class 2 Immunology device with product code JHI cleared through the Traditional 510(k) pathway after a 39-day FDA review.

K821657 · Biogenex Laboratories · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1982
Decision
39d
Days
Class 2
Risk

K821657 is an FDA 510(k) clearance for the RIAGEN B-HCG RIA. Classified as Visual, Pregnancy Hcg, Prescription Use (product code JHI), Class II - Special Controls.

Submitted by Biogenex Laboratories (Mchenry, US). The FDA issued a Cleared decision on July 13, 1982 after a review of 39 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1155 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Biogenex Laboratories devices

FDA 510(k) Submission Details - K821657

510(k) Number K821657 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 1982
Decision Date July 13, 1982
Days to Decision 39 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 105d · This submission: 39d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JHI Device Classification - Class 2, Special Controls

Product Code JHI Visual, Pregnancy Hcg, Prescription Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - JHI Visual, Pregnancy Hcg, Prescription Use

All 294
Devices cleared under the same product code (JHI) and FDA review panel - the closest regulatory comparables to K821657.
IN VITRO GAMMACOAT B-HCG RADIO. TEST
K823313 · Clinical Assays, Inc. · Dec 1982
B-HCG
K822343 · Diagnostic Products Corp. · Sep 1982
TANDEM HCG IMMUNOEZYMETRIC ASSAY KIT
K821944 · Hybritech, Inc. · Jul 1982
ROCHE(R) B-HCG RIA URINE STANDARD
K820942 · Hoffmann-La Roche, Inc. · May 1982
AMERLEX B-LCG RIA KIT
K821031 · Amersham Corp. · May 1982
TANDEM HCG KIT
K820822 · Hybritech, Inc. · Apr 1982